Validation of the EORTC QLQ-BIL21 questionnaire for measuring quality of life in patients with cholangiocarcinoma and cancer of the gallbladder.
Kaupp-Roberts, S Yadegarfar, G Friend, E O'Donnell, C Byrne, C Bahar, I Finch-Jones, M Gillmore, R Johnson, C
Kaupp-Roberts, S
Yadegarfar, G
Friend, E
O'Donnell, C
Byrne, C
Bahar, I
Finch-Jones, M
Gillmore, R
Johnson, C
Citations
Altmetric:
Abstract
There is no specific quality of life (QoL) measurement tool to quantify QoL in patients with biliary tract cancer. Quality of life measurement is an increasingly crucial trial end point and is now being incorporated into clinical practice.
Description
Date
2016-09-27
Publisher
Collections
Keywords
Type
Article
Citation
Validation of the EORTC QLQ-BIL21 questionnaire for measuring quality of life in patients with cholangiocarcinoma and cancer of the gallbladder. 2016, 115(9):1032-1038 Br. J. Cancer